FdaApplication
ANDA 212705
Identifiers
- fda_app_no: ANDA212705
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2020-07-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN | NAPROXEN | 25MG/ML | SUSPENSION;ORAL |
1 product